Micrus Endovascular receives FDA clearance for Watusi guidewire

By E. Janene Geiss

Philadelphia, May 11 - Micrus Endovascular Corp. said Thursday that it has received Food and Drug Administration clearance to market its Watusi guidewire platform in the United States.

This product line received CE Mark clearances in March 2006 and is currently marketed in the European Union. Micrus intends to begin selling this product through its domestic direct sales force immediately, according to a company news release.

"U.S. clearance of our Watusi guidewires expands our domestic product offering, allowing us to capture more of the embolic procedure dollar," said John Kilcoyne, Micrus president and chief executive officer.

Micrus Endovascular, based in San Jose, Calif., develops, manufactures and markets both implantable and disposable medical devices used in the treatment of cerebral vascular diseases.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.